Read + Share
Ma Y, Zhao H, Xue J, Liu L, et al. First-in-human phase I study of TQ-B3139 (CT-711) in advanced non-small cell lung
cancer patients with ALK and ROS1 rearrangements. Eur J Cancer 2022;173:238-249.
PMID: 35940055
|
 |
|
Ma Y, Zhao H, Xue J, Liu L, et al. First-in-human phase I study of TQ-B3139 (CT-711) in advanced non-small cell lung
cancer patients with ALK and ROS1 rearrangements. Eur J Cancer 2022;173:238-249.
PMID: 35940055
|
|
|
|